nodes	percent_of_prediction	percent_of_DWPC	metapath
Indinavir—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0903	0.13	CbGbCtD
Indinavir—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.0794	0.114	CbGbCtD
Indinavir—SLCO1A2—Prednisone—systemic scleroderma	0.0765	0.11	CbGbCtD
Indinavir—ABCB1—Lisinopril—systemic scleroderma	0.0439	0.063	CbGbCtD
Indinavir—CYP2C9—Leflunomide—systemic scleroderma	0.0431	0.0619	CbGbCtD
Indinavir—ABCC1—Methotrexate—systemic scleroderma	0.043	0.0617	CbGbCtD
Indinavir—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0397	0.0571	CbGbCtD
Indinavir—SLCO1A2—Methotrexate—systemic scleroderma	0.0384	0.0551	CbGbCtD
Indinavir—SLCO1B1—Methotrexate—systemic scleroderma	0.0362	0.052	CbGbCtD
Indinavir—ABCB1—Captopril—systemic scleroderma	0.0329	0.0472	CbGbCtD
Indinavir—ABCC2—Methotrexate—systemic scleroderma	0.0318	0.0457	CbGbCtD
Indinavir—CYP2D6—Captopril—systemic scleroderma	0.031	0.0444	CbGbCtD
Indinavir—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0259	0.0371	CbGbCtD
Indinavir—CYP2C19—Prednisone—systemic scleroderma	0.0256	0.0368	CbGbCtD
Indinavir—ABCB1—Prednisone—systemic scleroderma	0.0207	0.0297	CbGbCtD
Indinavir—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0155	0.0222	CbGbCtD
Indinavir—CYP3A4—Prednisone—systemic scleroderma	0.0124	0.0178	CbGbCtD
Indinavir—ABCB1—Methotrexate—systemic scleroderma	0.0104	0.0149	CbGbCtD
Indinavir—Agitation—Mycophenolate mofetil—systemic scleroderma	0.000203	0.000668	CcSEcCtD
Indinavir—Shock—Lisinopril—systemic scleroderma	0.000202	0.000666	CcSEcCtD
Indinavir—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000201	0.000664	CcSEcCtD
Indinavir—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000201	0.000663	CcSEcCtD
Indinavir—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000201	0.000662	CcSEcCtD
Indinavir—Abdominal pain—Azathioprine—systemic scleroderma	0.0002	0.00066	CcSEcCtD
Indinavir—Body temperature increased—Azathioprine—systemic scleroderma	0.0002	0.00066	CcSEcCtD
Indinavir—Skin disorder—Lisinopril—systemic scleroderma	0.000199	0.000658	CcSEcCtD
Indinavir—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000199	0.000656	CcSEcCtD
Indinavir—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000199	0.000655	CcSEcCtD
Indinavir—Diarrhoea—Captopril—systemic scleroderma	0.000198	0.000654	CcSEcCtD
Indinavir—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000198	0.000654	CcSEcCtD
Indinavir—Vertigo—Mycophenolate mofetil—systemic scleroderma	0.000198	0.000653	CcSEcCtD
Indinavir—Syncope—Mycophenolate mofetil—systemic scleroderma	0.000198	0.000652	CcSEcCtD
Indinavir—Feeling abnormal—Leflunomide—systemic scleroderma	0.000197	0.000649	CcSEcCtD
Indinavir—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000197	0.000649	CcSEcCtD
Indinavir—Fatigue—Mycophenolic acid—systemic scleroderma	0.000197	0.000648	CcSEcCtD
Indinavir—Nausea—Mometasone—systemic scleroderma	0.000196	0.000647	CcSEcCtD
Indinavir—Anorexia—Lisinopril—systemic scleroderma	0.000196	0.000645	CcSEcCtD
Indinavir—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000195	0.000644	CcSEcCtD
Indinavir—Weight increased—Prednisone—systemic scleroderma	0.000195	0.000644	CcSEcCtD
Indinavir—Pain—Mycophenolic acid—systemic scleroderma	0.000195	0.000643	CcSEcCtD
Indinavir—Constipation—Mycophenolic acid—systemic scleroderma	0.000195	0.000643	CcSEcCtD
Indinavir—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.000195	0.000642	CcSEcCtD
Indinavir—Loss of consciousness—Mycophenolate mofetil—systemic scleroderma	0.000194	0.000639	CcSEcCtD
Indinavir—Hyperglycaemia—Prednisone—systemic scleroderma	0.000193	0.000638	CcSEcCtD
Indinavir—Cough—Mycophenolate mofetil—systemic scleroderma	0.000192	0.000634	CcSEcCtD
Indinavir—Dizziness—Captopril—systemic scleroderma	0.000192	0.000632	CcSEcCtD
Indinavir—Urticaria—Leflunomide—systemic scleroderma	0.00019	0.000626	CcSEcCtD
Indinavir—Abdominal pain—Leflunomide—systemic scleroderma	0.000189	0.000623	CcSEcCtD
Indinavir—Body temperature increased—Leflunomide—systemic scleroderma	0.000189	0.000623	CcSEcCtD
Indinavir—Acute coronary syndrome—Prednisone—systemic scleroderma	0.000189	0.000622	CcSEcCtD
Indinavir—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000188	0.00062	CcSEcCtD
Indinavir—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000188	0.000619	CcSEcCtD
Indinavir—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000188	0.000619	CcSEcCtD
Indinavir—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000188	0.000619	CcSEcCtD
Indinavir—Myocardial infarction—Prednisone—systemic scleroderma	0.000187	0.000618	CcSEcCtD
Indinavir—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000187	0.000618	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000187	0.000617	CcSEcCtD
Indinavir—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000187	0.000617	CcSEcCtD
Indinavir—Hypersensitivity—Azathioprine—systemic scleroderma	0.000186	0.000615	CcSEcCtD
Indinavir—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000186	0.000615	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000186	0.000615	CcSEcCtD
Indinavir—Insomnia—Lisinopril—systemic scleroderma	0.000186	0.000612	CcSEcCtD
Indinavir—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000185	0.000611	CcSEcCtD
Indinavir—Paraesthesia—Lisinopril—systemic scleroderma	0.000184	0.000608	CcSEcCtD
Indinavir—Vomiting—Captopril—systemic scleroderma	0.000184	0.000608	CcSEcCtD
Indinavir—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000184	0.000605	CcSEcCtD
Indinavir—Dyspnoea—Lisinopril—systemic scleroderma	0.000183	0.000604	CcSEcCtD
Indinavir—Rash—Captopril—systemic scleroderma	0.000183	0.000603	CcSEcCtD
Indinavir—Dermatitis—Captopril—systemic scleroderma	0.000183	0.000602	CcSEcCtD
Indinavir—Somnolence—Lisinopril—systemic scleroderma	0.000183	0.000602	CcSEcCtD
Indinavir—Headache—Captopril—systemic scleroderma	0.000182	0.000599	CcSEcCtD
Indinavir—Dyspepsia—Lisinopril—systemic scleroderma	0.000181	0.000596	CcSEcCtD
Indinavir—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.00018	0.000594	CcSEcCtD
Indinavir—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.00018	0.000594	CcSEcCtD
Indinavir—Oedema—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000593	CcSEcCtD
Indinavir—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.00018	0.000593	CcSEcCtD
Indinavir—Decreased appetite—Lisinopril—systemic scleroderma	0.000179	0.000589	CcSEcCtD
Indinavir—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000177	0.000585	CcSEcCtD
Indinavir—Fatigue—Lisinopril—systemic scleroderma	0.000177	0.000584	CcSEcCtD
Indinavir—Shock—Mycophenolate mofetil—systemic scleroderma	0.000177	0.000584	CcSEcCtD
Indinavir—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000176	0.000582	CcSEcCtD
Indinavir—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.000176	0.000581	CcSEcCtD
Indinavir—Hypersensitivity—Leflunomide—systemic scleroderma	0.000176	0.000581	CcSEcCtD
Indinavir—Pancreatitis—Methotrexate—systemic scleroderma	0.000176	0.000579	CcSEcCtD
Indinavir—Pain—Lisinopril—systemic scleroderma	0.000176	0.000579	CcSEcCtD
Indinavir—Constipation—Lisinopril—systemic scleroderma	0.000176	0.000579	CcSEcCtD
Indinavir—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000175	0.000576	CcSEcCtD
Indinavir—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000574	CcSEcCtD
Indinavir—Diarrhoea—Azathioprine—systemic scleroderma	0.000173	0.000571	CcSEcCtD
Indinavir—Haemoglobin—Prednisone—systemic scleroderma	0.000173	0.000569	CcSEcCtD
Indinavir—Nausea—Captopril—systemic scleroderma	0.000172	0.000568	CcSEcCtD
Indinavir—Haemorrhage—Prednisone—systemic scleroderma	0.000172	0.000566	CcSEcCtD
Indinavir—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000172	0.000566	CcSEcCtD
Indinavir—Asthenia—Leflunomide—systemic scleroderma	0.000171	0.000565	CcSEcCtD
Indinavir—Feeling abnormal—Lisinopril—systemic scleroderma	0.000169	0.000558	CcSEcCtD
Indinavir—Pruritus—Leflunomide—systemic scleroderma	0.000169	0.000558	CcSEcCtD
Indinavir—Connective tissue disorder—Prednisone—systemic scleroderma	0.000169	0.000556	CcSEcCtD
Indinavir—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000168	0.000554	CcSEcCtD
Indinavir—Dysuria—Methotrexate—systemic scleroderma	0.000168	0.000553	CcSEcCtD
Indinavir—Dizziness—Azathioprine—systemic scleroderma	0.000167	0.000552	CcSEcCtD
Indinavir—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000167	0.000549	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000541	CcSEcCtD
Indinavir—Asthenia—Mycophenolic acid—systemic scleroderma	0.000164	0.000539	CcSEcCtD
Indinavir—Diarrhoea—Leflunomide—systemic scleroderma	0.000164	0.000539	CcSEcCtD
Indinavir—Urticaria—Lisinopril—systemic scleroderma	0.000163	0.000538	CcSEcCtD
Indinavir—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000163	0.000537	CcSEcCtD
Indinavir—Abdominal pain—Lisinopril—systemic scleroderma	0.000162	0.000535	CcSEcCtD
Indinavir—Body temperature increased—Lisinopril—systemic scleroderma	0.000162	0.000535	CcSEcCtD
Indinavir—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000162	0.000533	CcSEcCtD
Indinavir—Pruritus—Mycophenolic acid—systemic scleroderma	0.000161	0.000532	CcSEcCtD
Indinavir—Vomiting—Azathioprine—systemic scleroderma	0.000161	0.000531	CcSEcCtD
Indinavir—Pneumonia—Methotrexate—systemic scleroderma	0.000161	0.00053	CcSEcCtD
Indinavir—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000529	CcSEcCtD
Indinavir—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000527	CcSEcCtD
Indinavir—Rash—Azathioprine—systemic scleroderma	0.00016	0.000526	CcSEcCtD
Indinavir—Dermatitis—Azathioprine—systemic scleroderma	0.000159	0.000526	CcSEcCtD
Indinavir—Flushing—Prednisone—systemic scleroderma	0.000159	0.000525	CcSEcCtD
Indinavir—Headache—Azathioprine—systemic scleroderma	0.000159	0.000523	CcSEcCtD
Indinavir—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000158	0.000522	CcSEcCtD
Indinavir—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000522	CcSEcCtD
Indinavir—Dizziness—Leflunomide—systemic scleroderma	0.000158	0.000521	CcSEcCtD
Indinavir—Renal failure—Methotrexate—systemic scleroderma	0.000157	0.000518	CcSEcCtD
Indinavir—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000516	CcSEcCtD
Indinavir—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000156	0.000514	CcSEcCtD
Indinavir—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000155	0.000512	CcSEcCtD
Indinavir—Immune system disorder—Prednisone—systemic scleroderma	0.000155	0.000511	CcSEcCtD
Indinavir—Pain—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000507	CcSEcCtD
Indinavir—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000154	0.000507	CcSEcCtD
Indinavir—Sweating—Methotrexate—systemic scleroderma	0.000153	0.000505	CcSEcCtD
Indinavir—Haematuria—Methotrexate—systemic scleroderma	0.000152	0.000502	CcSEcCtD
Indinavir—Vomiting—Leflunomide—systemic scleroderma	0.000152	0.000501	CcSEcCtD
Indinavir—Alopecia—Prednisone—systemic scleroderma	0.000152	0.0005	CcSEcCtD
Indinavir—Hypersensitivity—Lisinopril—systemic scleroderma	0.000151	0.000499	CcSEcCtD
Indinavir—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000151	0.000498	CcSEcCtD
Indinavir—Dizziness—Mycophenolic acid—systemic scleroderma	0.000151	0.000497	CcSEcCtD
Indinavir—Rash—Leflunomide—systemic scleroderma	0.000151	0.000497	CcSEcCtD
Indinavir—Dermatitis—Leflunomide—systemic scleroderma	0.000151	0.000496	CcSEcCtD
Indinavir—Nausea—Azathioprine—systemic scleroderma	0.00015	0.000496	CcSEcCtD
Indinavir—Headache—Leflunomide—systemic scleroderma	0.00015	0.000494	CcSEcCtD
Indinavir—Malnutrition—Prednisone—systemic scleroderma	0.000149	0.000493	CcSEcCtD
Indinavir—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000489	CcSEcCtD
Indinavir—Asthenia—Lisinopril—systemic scleroderma	0.000147	0.000486	CcSEcCtD
Indinavir—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000147	0.000485	CcSEcCtD
Indinavir—Pruritus—Lisinopril—systemic scleroderma	0.000145	0.000479	CcSEcCtD
Indinavir—Vomiting—Mycophenolic acid—systemic scleroderma	0.000145	0.000478	CcSEcCtD
Indinavir—Haemoglobin—Methotrexate—systemic scleroderma	0.000144	0.000475	CcSEcCtD
Indinavir—Rash—Mycophenolic acid—systemic scleroderma	0.000144	0.000474	CcSEcCtD
Indinavir—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000144	0.000474	CcSEcCtD
Indinavir—Haemorrhage—Methotrexate—systemic scleroderma	0.000143	0.000473	CcSEcCtD
Indinavir—Hepatitis—Methotrexate—systemic scleroderma	0.000143	0.000473	CcSEcCtD
Indinavir—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000143	0.000471	CcSEcCtD
Indinavir—Headache—Mycophenolic acid—systemic scleroderma	0.000143	0.000471	CcSEcCtD
Indinavir—Pharyngitis—Methotrexate—systemic scleroderma	0.000142	0.00047	CcSEcCtD
Indinavir—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000469	CcSEcCtD
Indinavir—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000142	0.000469	CcSEcCtD
Indinavir—Nausea—Leflunomide—systemic scleroderma	0.000142	0.000468	CcSEcCtD
Indinavir—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000142	0.000467	CcSEcCtD
Indinavir—Vision blurred—Prednisone—systemic scleroderma	0.000141	0.000464	CcSEcCtD
Indinavir—Urethral disorder—Methotrexate—systemic scleroderma	0.000141	0.000464	CcSEcCtD
Indinavir—Diarrhoea—Lisinopril—systemic scleroderma	0.000141	0.000463	CcSEcCtD
Indinavir—Ill-defined disorder—Prednisone—systemic scleroderma	0.000139	0.000457	CcSEcCtD
Indinavir—Anaemia—Prednisone—systemic scleroderma	0.000138	0.000455	CcSEcCtD
Indinavir—Agitation—Prednisone—systemic scleroderma	0.000137	0.000453	CcSEcCtD
Indinavir—Angioedema—Prednisone—systemic scleroderma	0.000137	0.00045	CcSEcCtD
Indinavir—Dizziness—Lisinopril—systemic scleroderma	0.000136	0.000448	CcSEcCtD
Indinavir—Erythema multiforme—Methotrexate—systemic scleroderma	0.000136	0.000447	CcSEcCtD
Indinavir—Nausea—Mycophenolic acid—systemic scleroderma	0.000135	0.000447	CcSEcCtD
Indinavir—Malaise—Prednisone—systemic scleroderma	0.000135	0.000444	CcSEcCtD
Indinavir—Vertigo—Prednisone—systemic scleroderma	0.000134	0.000443	CcSEcCtD
Indinavir—Syncope—Prednisone—systemic scleroderma	0.000134	0.000442	CcSEcCtD
Indinavir—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000133	0.000437	CcSEcCtD
Indinavir—Loss of consciousness—Prednisone—systemic scleroderma	0.000131	0.000433	CcSEcCtD
Indinavir—Vomiting—Lisinopril—systemic scleroderma	0.000131	0.000431	CcSEcCtD
Indinavir—Immune system disorder—Methotrexate—systemic scleroderma	0.00013	0.000427	CcSEcCtD
Indinavir—Rash—Lisinopril—systemic scleroderma	0.000129	0.000427	CcSEcCtD
Indinavir—Dermatitis—Lisinopril—systemic scleroderma	0.000129	0.000427	CcSEcCtD
Indinavir—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000129	0.000426	CcSEcCtD
Indinavir—Chills—Methotrexate—systemic scleroderma	0.000129	0.000424	CcSEcCtD
Indinavir—Headache—Lisinopril—systemic scleroderma	0.000129	0.000424	CcSEcCtD
Indinavir—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000127	0.00042	CcSEcCtD
Indinavir—Arthralgia—Prednisone—systemic scleroderma	0.000127	0.00042	CcSEcCtD
Indinavir—Myalgia—Prednisone—systemic scleroderma	0.000127	0.00042	CcSEcCtD
Indinavir—Anxiety—Prednisone—systemic scleroderma	0.000127	0.000418	CcSEcCtD
Indinavir—Alopecia—Methotrexate—systemic scleroderma	0.000127	0.000418	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000126	0.000417	CcSEcCtD
Indinavir—Discomfort—Prednisone—systemic scleroderma	0.000126	0.000414	CcSEcCtD
Indinavir—Malnutrition—Methotrexate—systemic scleroderma	0.000125	0.000412	CcSEcCtD
Indinavir—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000123	0.000406	CcSEcCtD
Indinavir—Dysgeusia—Methotrexate—systemic scleroderma	0.000122	0.000403	CcSEcCtD
Indinavir—Nausea—Lisinopril—systemic scleroderma	0.000122	0.000402	CcSEcCtD
Indinavir—Anaphylactic shock—Prednisone—systemic scleroderma	0.000122	0.000402	CcSEcCtD
Indinavir—Oedema—Prednisone—systemic scleroderma	0.000122	0.000402	CcSEcCtD
Indinavir—Back pain—Methotrexate—systemic scleroderma	0.000121	0.000398	CcSEcCtD
Indinavir—Shock—Prednisone—systemic scleroderma	0.00012	0.000396	CcSEcCtD
Indinavir—Nervous system disorder—Prednisone—systemic scleroderma	0.00012	0.000394	CcSEcCtD
Indinavir—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000119	0.000392	CcSEcCtD
Indinavir—Skin disorder—Prednisone—systemic scleroderma	0.000118	0.000391	CcSEcCtD
Indinavir—Hyperhidrosis—Prednisone—systemic scleroderma	0.000118	0.000389	CcSEcCtD
Indinavir—Vision blurred—Methotrexate—systemic scleroderma	0.000118	0.000388	CcSEcCtD
Indinavir—Anorexia—Prednisone—systemic scleroderma	0.000116	0.000383	CcSEcCtD
Indinavir—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000116	0.000382	CcSEcCtD
Indinavir—Anaemia—Methotrexate—systemic scleroderma	0.000115	0.000381	CcSEcCtD
Indinavir—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000114	0.000377	CcSEcCtD
Indinavir—Rash—Mycophenolate mofetil—systemic scleroderma	0.000113	0.000374	CcSEcCtD
Indinavir—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000113	0.000374	CcSEcCtD
Indinavir—Headache—Mycophenolate mofetil—systemic scleroderma	0.000113	0.000372	CcSEcCtD
Indinavir—Malaise—Methotrexate—systemic scleroderma	0.000113	0.000371	CcSEcCtD
Indinavir—Vertigo—Methotrexate—systemic scleroderma	0.000112	0.00037	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000111	0.000366	CcSEcCtD
Indinavir—Insomnia—Prednisone—systemic scleroderma	0.00011	0.000364	CcSEcCtD
Indinavir—Paraesthesia—Prednisone—systemic scleroderma	0.00011	0.000361	CcSEcCtD
Indinavir—Cough—Methotrexate—systemic scleroderma	0.000109	0.000359	CcSEcCtD
Indinavir—Dyspepsia—Prednisone—systemic scleroderma	0.000107	0.000354	CcSEcCtD
Indinavir—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000107	0.000352	CcSEcCtD
Indinavir—Chest pain—Methotrexate—systemic scleroderma	0.000106	0.000351	CcSEcCtD
Indinavir—Arthralgia—Methotrexate—systemic scleroderma	0.000106	0.000351	CcSEcCtD
Indinavir—Myalgia—Methotrexate—systemic scleroderma	0.000106	0.000351	CcSEcCtD
Indinavir—Decreased appetite—Prednisone—systemic scleroderma	0.000106	0.00035	CcSEcCtD
Indinavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000106	0.000348	CcSEcCtD
Indinavir—Fatigue—Prednisone—systemic scleroderma	0.000105	0.000347	CcSEcCtD
Indinavir—Discomfort—Methotrexate—systemic scleroderma	0.000105	0.000346	CcSEcCtD
Indinavir—Constipation—Prednisone—systemic scleroderma	0.000104	0.000344	CcSEcCtD
Indinavir—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000102	0.000336	CcSEcCtD
Indinavir—Feeling abnormal—Prednisone—systemic scleroderma	0.000101	0.000331	CcSEcCtD
Indinavir—Nervous system disorder—Methotrexate—systemic scleroderma	0.0001	0.00033	CcSEcCtD
Indinavir—Thrombocytopenia—Methotrexate—systemic scleroderma	9.98e-05	0.000329	CcSEcCtD
Indinavir—Gastrointestinal pain—Prednisone—systemic scleroderma	9.97e-05	0.000329	CcSEcCtD
Indinavir—Skin disorder—Methotrexate—systemic scleroderma	9.9e-05	0.000326	CcSEcCtD
Indinavir—Hyperhidrosis—Methotrexate—systemic scleroderma	9.85e-05	0.000325	CcSEcCtD
Indinavir—Anorexia—Methotrexate—systemic scleroderma	9.72e-05	0.00032	CcSEcCtD
Indinavir—Urticaria—Prednisone—systemic scleroderma	9.69e-05	0.000319	CcSEcCtD
Indinavir—Body temperature increased—Prednisone—systemic scleroderma	9.64e-05	0.000318	CcSEcCtD
Indinavir—Abdominal pain—Prednisone—systemic scleroderma	9.64e-05	0.000318	CcSEcCtD
Indinavir—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	9.29e-05	0.000306	CcSEcCtD
Indinavir—Insomnia—Methotrexate—systemic scleroderma	9.22e-05	0.000304	CcSEcCtD
Indinavir—Paraesthesia—Methotrexate—systemic scleroderma	9.15e-05	0.000302	CcSEcCtD
Indinavir—Dyspnoea—Methotrexate—systemic scleroderma	9.09e-05	0.0003	CcSEcCtD
Indinavir—Somnolence—Methotrexate—systemic scleroderma	9.06e-05	0.000299	CcSEcCtD
Indinavir—Hypersensitivity—Prednisone—systemic scleroderma	8.99e-05	0.000296	CcSEcCtD
Indinavir—Dyspepsia—Methotrexate—systemic scleroderma	8.97e-05	0.000296	CcSEcCtD
Indinavir—Decreased appetite—Methotrexate—systemic scleroderma	8.86e-05	0.000292	CcSEcCtD
Indinavir—Gastrointestinal disorder—Methotrexate—systemic scleroderma	8.8e-05	0.00029	CcSEcCtD
Indinavir—Fatigue—Methotrexate—systemic scleroderma	8.79e-05	0.00029	CcSEcCtD
Indinavir—Asthenia—Prednisone—systemic scleroderma	8.75e-05	0.000289	CcSEcCtD
Indinavir—Pain—Methotrexate—systemic scleroderma	8.72e-05	0.000287	CcSEcCtD
Indinavir—Pruritus—Prednisone—systemic scleroderma	8.63e-05	0.000285	CcSEcCtD
Indinavir—Feeling abnormal—Methotrexate—systemic scleroderma	8.4e-05	0.000277	CcSEcCtD
Indinavir—Diarrhoea—Prednisone—systemic scleroderma	8.35e-05	0.000275	CcSEcCtD
Indinavir—Gastrointestinal pain—Methotrexate—systemic scleroderma	8.34e-05	0.000275	CcSEcCtD
Indinavir—Urticaria—Methotrexate—systemic scleroderma	8.1e-05	0.000267	CcSEcCtD
Indinavir—Dizziness—Prednisone—systemic scleroderma	8.07e-05	0.000266	CcSEcCtD
Indinavir—Abdominal pain—Methotrexate—systemic scleroderma	8.06e-05	0.000266	CcSEcCtD
Indinavir—Body temperature increased—Methotrexate—systemic scleroderma	8.06e-05	0.000266	CcSEcCtD
Indinavir—Vomiting—Prednisone—systemic scleroderma	7.76e-05	0.000256	CcSEcCtD
Indinavir—Rash—Prednisone—systemic scleroderma	7.69e-05	0.000254	CcSEcCtD
Indinavir—Dermatitis—Prednisone—systemic scleroderma	7.68e-05	0.000253	CcSEcCtD
Indinavir—Headache—Prednisone—systemic scleroderma	7.64e-05	0.000252	CcSEcCtD
Indinavir—Hypersensitivity—Methotrexate—systemic scleroderma	7.51e-05	0.000248	CcSEcCtD
Indinavir—Asthenia—Methotrexate—systemic scleroderma	7.31e-05	0.000241	CcSEcCtD
Indinavir—Nausea—Prednisone—systemic scleroderma	7.25e-05	0.000239	CcSEcCtD
Indinavir—Pruritus—Methotrexate—systemic scleroderma	7.21e-05	0.000238	CcSEcCtD
Indinavir—Diarrhoea—Methotrexate—systemic scleroderma	6.97e-05	0.00023	CcSEcCtD
Indinavir—Dizziness—Methotrexate—systemic scleroderma	6.74e-05	0.000222	CcSEcCtD
Indinavir—Vomiting—Methotrexate—systemic scleroderma	6.48e-05	0.000214	CcSEcCtD
Indinavir—Rash—Methotrexate—systemic scleroderma	6.43e-05	0.000212	CcSEcCtD
Indinavir—Dermatitis—Methotrexate—systemic scleroderma	6.42e-05	0.000212	CcSEcCtD
Indinavir—Headache—Methotrexate—systemic scleroderma	6.39e-05	0.000211	CcSEcCtD
Indinavir—Nausea—Methotrexate—systemic scleroderma	6.05e-05	0.0002	CcSEcCtD
